vs
通用电气医疗（OPCH）与利氏兄弟拍卖行（RBA）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是利氏兄弟拍卖行的1.1倍（$1.4B vs $1.2B），利氏兄弟拍卖行净利率更高（9.1% vs 3.4%，领先5.8%），利氏兄弟拍卖行同比增速更快（5.4% vs 1.3%），过去两年利氏兄弟拍卖行的营收复合增速更高（6.3% vs 4.9%）
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
利氏兄弟拍卖行（股票代码RBA）是全球知名的工业资产拍卖服务商，注册地位于加拿大，属公开上市企业，总部设在美国伊利诺伊州韦斯特切斯特，普通股同时在多伦多证券交易所与纽约证券交易所挂牌交易。
OPCH vs RBA — 直观对比
营收规模更大
OPCH
是对方的1.1倍
$1.2B
营收增速更快
RBA
高出4.1%
1.3%
净利率更高
RBA
高出5.8%
3.4%
两年增速更快
RBA
近两年复合增速
4.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.2B |
| 净利润 | $45.3M | $109.7M |
| 毛利率 | 19.4% | — |
| 营业利润率 | 5.4% | 14.7% |
| 净利率 | 3.4% | 9.1% |
| 营收同比 | 1.3% | 5.4% |
| 净利润同比 | -3.0% | -7.4% |
| 每股收益（稀释后） | $0.29 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OPCHRBA
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.4B | $1.1B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.3B | $1.1B | ||
| Q4 24 | $1.3B | $1.1B | ||
| Q3 24 | $1.3B | $981.8M | ||
| Q2 24 | $1.2B | $1.1B |
净利润OPCHRBA
| Q1 26 | $45.3M | — | ||
| Q4 25 | $58.5M | $109.7M | ||
| Q3 25 | $51.8M | $95.5M | ||
| Q2 25 | $50.5M | $109.8M | ||
| Q1 25 | $46.7M | $113.4M | ||
| Q4 24 | $60.1M | $118.5M | ||
| Q3 24 | $53.9M | $76.1M | ||
| Q2 24 | $53.0M | $111.1M |
毛利率OPCHRBA
| Q1 26 | 19.4% | — | ||
| Q4 25 | 19.3% | — | ||
| Q3 25 | 19.0% | — | ||
| Q2 25 | 19.0% | — | ||
| Q1 25 | 19.7% | — | ||
| Q4 24 | 21.3% | — | ||
| Q3 24 | 20.1% | — | ||
| Q2 24 | 20.3% | — |
营业利润率OPCHRBA
| Q1 26 | 5.4% | — | ||
| Q4 25 | 6.2% | 14.7% | ||
| Q3 25 | 5.9% | 14.5% | ||
| Q2 25 | 5.8% | 15.9% | ||
| Q1 25 | 5.9% | 17.1% | ||
| Q4 24 | 6.9% | 18.1% | ||
| Q3 24 | 6.7% | 15.6% | ||
| Q2 24 | 6.6% | 18.4% |
净利率OPCHRBA
| Q1 26 | 3.4% | — | ||
| Q4 25 | 4.0% | 9.1% | ||
| Q3 25 | 3.6% | 8.7% | ||
| Q2 25 | 3.6% | 9.3% | ||
| Q1 25 | 3.5% | 10.2% | ||
| Q4 24 | 4.8% | 10.4% | ||
| Q3 24 | 4.2% | 7.8% | ||
| Q2 24 | 4.3% | 10.1% |
每股收益（稀释后）OPCHRBA
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.37 | $0.53 | ||
| Q3 25 | $0.32 | $0.43 | ||
| Q2 25 | $0.31 | $0.53 | ||
| Q1 25 | $0.28 | $0.55 | ||
| Q4 24 | $0.36 | $0.58 | ||
| Q3 24 | $0.31 | $0.36 | ||
| Q2 24 | $0.30 | $0.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $177.3M | $531.5M |
| 总债务越低越好 | — | $2.3B |
| 股东权益账面价值 | — | $5.6B |
| 总资产 | $3.4B | $12.1B |
| 负债/权益比越低杠杆越低 | — | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资OPCHRBA
| Q1 26 | $177.3M | — | ||
| Q4 25 | $232.6M | $531.5M | ||
| Q3 25 | $309.8M | $674.7M | ||
| Q2 25 | $198.8M | $710.2M | ||
| Q1 25 | $171.4M | $578.1M | ||
| Q4 24 | $412.6M | $533.9M | ||
| Q3 24 | $483.0M | $650.7M | ||
| Q2 24 | $376.9M | $599.5M |
总债务OPCHRBA
| Q1 26 | — | — | ||
| Q4 25 | — | $2.3B | ||
| Q3 25 | $1.2B | $2.6B | ||
| Q2 25 | $1.1B | $2.6B | ||
| Q1 25 | $1.1B | $2.6B | ||
| Q4 24 | $1.1B | $2.6B | ||
| Q3 24 | $1.1B | $2.7B | ||
| Q2 24 | $1.1B | $2.8B |
股东权益OPCHRBA
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $5.6B | ||
| Q3 25 | $1.4B | $5.5B | ||
| Q2 25 | $1.4B | $5.5B | ||
| Q1 25 | $1.4B | $5.3B | ||
| Q4 24 | $1.4B | $5.2B | ||
| Q3 24 | $1.4B | $5.2B | ||
| Q2 24 | $1.4B | $5.2B |
总资产OPCHRBA
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.5B | $12.1B | ||
| Q3 25 | $3.5B | $12.2B | ||
| Q2 25 | $3.4B | $12.2B | ||
| Q1 25 | $3.3B | $11.9B | ||
| Q4 24 | $3.4B | $11.8B | ||
| Q3 24 | $3.4B | $11.9B | ||
| Q2 24 | $3.3B | $12.1B |
负债/权益比OPCHRBA
| Q1 26 | — | — | ||
| Q4 25 | — | 0.42× | ||
| Q3 25 | 0.86× | 0.47× | ||
| Q2 25 | 0.82× | 0.47× | ||
| Q1 25 | 0.82× | 0.50× | ||
| Q4 24 | 0.79× | 0.50× | ||
| Q3 24 | 0.78× | 0.52× | ||
| Q2 24 | 0.79× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $255.2M |
| 自由现金流经营现金流 - 资本支出 | — | $186.5M |
| 自由现金流率自由现金流/营收 | — | 15.5% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | — | 2.33× |
| 过去12个月自由现金流最近4个季度 | — | $719.2M |
8季度趋势，按日历期对齐
经营现金流OPCHRBA
| Q1 26 | — | — | ||
| Q4 25 | $258.4M | $255.2M | ||
| Q3 25 | $139.4M | $239.7M | ||
| Q2 25 | $90.3M | $326.5M | ||
| Q1 25 | $-7.2M | $156.8M | ||
| Q4 24 | $36.1M | $184.5M | ||
| Q3 24 | $160.4M | $285.4M | ||
| Q2 24 | $195.7M | $337.3M |
自由现金流OPCHRBA
| Q1 26 | — | — | ||
| Q4 25 | — | $186.5M | ||
| Q3 25 | $130.2M | $188.5M | ||
| Q2 25 | $81.2M | $241.7M | ||
| Q1 25 | $-16.6M | $102.5M | ||
| Q4 24 | $25.8M | $127.9M | ||
| Q3 24 | $150.7M | $248.5M | ||
| Q2 24 | $185.9M | $308.6M |
自由现金流率OPCHRBA
| Q1 26 | — | — | ||
| Q4 25 | — | 15.5% | ||
| Q3 25 | 9.1% | 17.3% | ||
| Q2 25 | 5.7% | 20.4% | ||
| Q1 25 | -1.2% | 9.2% | ||
| Q4 24 | 2.0% | 11.2% | ||
| Q3 24 | 11.8% | 25.3% | ||
| Q2 24 | 15.1% | 28.2% |
资本支出强度OPCHRBA
| Q1 26 | — | — | ||
| Q4 25 | — | 5.7% | ||
| Q3 25 | 0.6% | 4.7% | ||
| Q2 25 | 0.6% | 7.2% | ||
| Q1 25 | 0.7% | 4.9% | ||
| Q4 24 | 0.8% | 5.0% | ||
| Q3 24 | 0.8% | 3.8% | ||
| Q2 24 | 0.8% | 2.6% |
现金转化率OPCHRBA
| Q1 26 | — | — | ||
| Q4 25 | 4.42× | 2.33× | ||
| Q3 25 | 2.69× | 2.51× | ||
| Q2 25 | 1.79× | 2.97× | ||
| Q1 25 | -0.15× | 1.38× | ||
| Q4 24 | 0.60× | 1.56× | ||
| Q3 24 | 2.98× | 3.75× | ||
| Q2 24 | 3.69× | 3.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OPCH
暂无分部数据
RBA
| Buyer Revenue | $577.2M | 48% |
| Seller Revenue | $255.2M | 21% |
| CA | $199.0M | 17% |
| Other | $124.7M | 10% |
| AU | $47.3M | 4% |
